Dr. Miguel Saps discusses his manuscript .
Ver Fuente Visitas: 2121
Multicenter Randomized Multicenter Randomized Placebo Controlled
David Karsenti on ".
Ver Fuente Visitas: 49
5th National Research and Development Conference (NRDC) | Department of Science and Technology | November 9-11, 2020..
Ver Fuente Visitas: 36
Originally presented at a Carilion Children's Pediatric CME Journal Club Conference by Ogocukwu Okoye, MD and Silvia Natalia ....
Ver Fuente Visitas: 60
Prednisolone multicenter Prednisolone multicenter randomized trial
This video was made for The Annals of Thoracic Surgery journal in contribution with the Society of Thoracic Surgeons. You can ....
Ver Fuente Visitas: 45
In this educational video we outline the rationale and key outcomes from the .
Ver Fuente Visitas: 527
Takaaki Morikawa on ".
Ver Fuente Visitas: 33
Find out how and why researchers use randomisation to test new treatments. All new treatments need to be tested in clinical trials ....
Ver Fuente Visitas: 156.949
Multicenter randomized.
Ver Fuente Visitas: 74
Ido Weinberg, MD of Massachusetts General Hospital presents during VIVA Late-breaking: ACT I .
Ver Fuente Visitas: 129
(This video was recorded on March 17th, 2025) Roger Seheult, MD is the co-founder and lead professor at ....
Ver Fuente Visitas: 13.274
Gel Stent Versus Trabeculectomy: The .
Ver Fuente Visitas: 14
In the latest MedCram video, Dr. Seheult examines a .
Ver Fuente Visitas: 4235
The July 2019 supplement of the The Bone and Joint Journal consists of papers from The Knee Society. In this episode, Mr Iain ....
Ver Fuente Visitas: 85
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help ....
Ver Fuente Visitas: 215
LBA3 - Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: results from a .
Ver Fuente Visitas: 1805
Lecturer: Prof. Marvin Zelen, Harvard University "Clinical Trials and Clinical Research" A conference that was held at the Tel Aviv ....
Ver Fuente Visitas: 871
No description available.
Ver Fuente Visitas: 48
1009 Jennifer R. Brown, et al. Fixed-Duration Acalabrutinib Plus Venetoclax with or without Obinutuzumab Versus ....
Ver Fuente Visitas: 78